Hydroxyzine evidence profile
The current human-facing label provides clinical context, but the pharmacokinetic paper attached to this draft studied exercised horses.
Hydroxyzine: evidence and interpretation notes
Why HalfLifeDB does not plot Hydroxyzine
The current human-facing label provides clinical context, but the pharmacokinetic paper attached to this draft studied exercised horses. A veterinary estimate is not carried into the public human model.
What each source contributes
- DailyMed: HYDROXYZINE PAMOATE CAPSULE [COUPLER LLC]. This product label adds formulation-specific pharmacokinetic context and does not represent every route or product.
- PubChem: Hydroxyzine. This identity record confirms names and compound identity and does not supply a human half-life.
- Pharmacokinetics of hydroxyzine and cetirizine following oral administration of hydroxyzine to exercised Thoroughbred horses. This preclinical study documents species-specific disposition or assay work and is not translated into a typical human estimate.
For Hydroxyzine, the decision to withhold a curve turns on the limits visible in DailyMed: HYDROXYZINE PAMOATE CAPSULE [COUPLER LLC]. This product label adds formulation-specific pharmacokinetic context, but it does not represent every route or product.
What evidence would change the page
A defensible Hydroxyzine curve would require repeated human samples and a reported estimate for Hydroxyzine itself, rather than an inference from species, cases, related compounds, or class behavior. The current key record, DailyMed: HYDROXYZINE PAMOATE CAPSULE [COUPLER LLC], answers a narrower question.
InterpretationCategory context and evidence limits
antihistamine context
Antihistamine profiles can show a gap between pharmacokinetic persistence and perceived sedation, alertness, or next-day effects.
- Sedation and anticholinergic effects are not predicted by the curve.
- Age, co-medications, and formulation can change practical interpretation.
- Detection, impairment, and safety questions require context beyond half-life.
EvidenceSource trail and model decision
Sources and evidence context
A linked record is not automatically proof of the displayed value. Study, labeling, review, and compound identity sources serve different purposes; notes below identify limitations when they are known.
- Official labeling DailyMed label: HYDROXYZINE PAMOATE CAPSULE [COUPLER LLC].Official U.S. product labeling used for formulation and labeled pharmacokinetic context; its statements apply to the described product.
- Identity record PubChem Compound Summary: Hydroxyzine.Compound identity and naming record. It supplies chemistry context, not independent numerical support for the model.
- Research abstract PubMed: Pharmacokinetics of hydroxyzine and cetirizine following oral administration of hydroxyzine to exercised Thoroughbred horses.Veterinary pharmacokinetic study; supplemental only and not a direct human half-life estimate.
BoundariesWhat this page cannot answer and where to continue
What this page does not answer
- It does not estimate impairment, intoxication, or fitness to drive.
- It does not predict urine, blood, saliva, or hair test results.
- It does not model repeated exposure, tolerance, withdrawal, or interactions.
- It does not replace clinician, pharmacist, toxicologist, or emergency guidance.
Continue with context
- All substance profiles
- Browse the antihistamine group
- Clearance and volume of distribution
- Bioavailability, route, and formulation
- Active metabolites and parent compounds
- First-order vs nonlinear kinetics
- Detection windows vs half-life
- Reading labels and source quality
Read the medical disclaimer, methodology, and research standards before using the model for comparison.